Reviews Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine


No reviews yet.

Tripedia Drug Description
Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Tripedia®
DRUG DESCRIPTION



What are the possible side effects of diphtheria, tetanus, and pertussis vaccines (Acel-Imune, Certiva, Daptacel, Infanrix, Tripedia)?

Keep track of any and all side effects your child has after receiving this vaccine. When the child receives the next booster dose, you will need to tell the doctor if the first shot caused any side effects. Getting diphtheria, tetanus, or pertussis disease is much riskier than getting DTaP vaccine. However, like any medicine, this vaccine, can cause side effects. The risk of DTaP vaccine causing a serious side effect is extremely...
Read All Potential Side Effects for Tripedia »




Tripedia®, Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP), for intramuscular use, is a sterile preparation of diphtheria and tetanus toxoids adsorbed, with acellular pertussis vaccine in an isotonic sodium chloride solution containing sodium phosphate to control pH. After shaking, the vaccine is a homogeneous white suspension. Tripedia vaccine is distributed by Aventis Pasteur Inc. (AvP).
Corynebacterium diphtheriae cultures are grown in a modified Mueller and Miller medium.1 Clostridium tetani cultures are grown in a peptone-based medium containing a bovine extract. The meat used in this medium is US sourced. Both toxins are detoxified with formaldehyde. The detoxified materials are then separately purified by serial ammonium sulfate fractionation and diafiltration.
The acellular pertussis vaccine components are isolated from culture fluids of Phase 1 Bordetella pertussis grown in a modified Stainer-Scholte medium.2 After purification by salt precipitation, ultracentrifugation, and ultrafiltration, preparations containing varying amounts of both pertussis toxin (PT) and filamentous hemagglutinin (FHA) are combined to obtain a 1:1 ratio and treated with formaldehyde to inactivate PT.
The diphtheria and tetanus toxoids are adsorbed using aluminum potassium sulfate (alum). The adsorbed toxoids are combined with acellular pertussis concentrate, and diluted to a final volume using sterile phosphate-buffered physiological saline.
Each 0.5 mL dose is formulated to contain 6.7 Lf of diphtheria toxoid and 5 Lf of tetanus toxoid (both toxoids induce at least 2 units of antitoxin per mL in the guinea pig potency test), and 46.8 mg of pertussis antigens. This is represented in the final vaccine as approximately 23.4 mg of inactivated PT and 23.4 mg of FHA. The inactivated acellular pertussis component contributes not more than 50 endotoxin units to the endotoxin content of 1 mL of DTaP. The potency of the pertussis components is evaluated by measuring the antibody response to PT and FHA in immunized mice using an ELISA system. The vaccine is formulated without preservatives, but contains a trace amount of thimerosal [(mercury derivative), (≤0.3 mg mercury/dose)] from the manufacturing process. Each 0.5 mL dose also contains, by assay, not more than 0.170 mg of aluminum and not more than 100 mg (0.02%) of residual formaldehyde. The vaccine contains gelatin and polysorbate 80 (Tween-80), which are used in the production of the pertussis concentrate.
Acellular Pertussis Vaccine Concentrates (For Further Manufacturing Use) are produced by The Research Foundation for Microbial Diseases of Osaka University (BIKEN), Osaka, Japan, under United States (US) license, and are combined with diphtheria and tetanus toxoids manufactured by AvP. Tripedia vaccine is filled, labeled, packaged, and released by AvP.
When Tripedia vaccine is used to reconstitute ActHIB[Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) manufactured by Aventis Pasteur SA] the combination vaccine is TriHIBit. Each single 0.5 mL dose of TriHIBit vaccine for the fourth dose only, is formulated to contain 6.7 Lf of diphtheria toxoid, 5 Lf of tetanus toxoid (both toxoids induce at least 2 units of antitoxin per mL in the guinea pig potency test), 46.8 mg of pertussis antigens (approximately 23.4 mg of inactivated PT and 23.4 mg of FHA), 10 mg of purified Haemophilus influenzae type b capsular polysaccharide conjugated to 24 mg of inactivated tetanus toxoid, and 8.5% sucrose. (Refer to ActHIB vaccine package insert.)
REFERENCES
1. Mueller JH, et al. Production of diphtheria toxin of high potency (100 Lf) on a reproducible medium. J Immunol 1941;40: 21-32.
2. Aventis Pasteur Inc. , Data on File 072503. Last reviewed on RxList: 6/8/2006




Tripedia Drug Description
Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Tripedia®
DRUG DESCRIPTION



What are the possible side effects of diphtheria, tetanus, and pertussis vaccines (Acel-Imune, Certiva, Daptacel, Infanrix, Tripedia)?

Keep track of any and all side effects your child has after receiving this vaccine. When the child receives the next booster dose, you will need to tell the doctor if the first shot caused any side effects. Getting diphtheria, tetanus, or pertussis disease is much riskier than getting DTaP vaccine. However, like any medicine, this vaccine, can cause side effects. The risk of DTaP vaccine causing a serious side effect is extremely...
Read All Potential Side Effects for Tripedia »




Tripedia®, Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP), for intramuscular use, is a sterile preparation of diphtheria and tetanus toxoids adsorbed, with acellular pertussis vaccine in an isotonic sodium chloride solution containing sodium phosphate to control pH. After shaking, the vaccine is a homogeneous white suspension. Tripedia vaccine is distributed by Aventis Pasteur Inc. (AvP).
Corynebacterium diphtheriae cultures are grown in a modified Mueller and Miller medium.1 Clostridium tetani cultures are grown in a peptone-based medium containing a bovine extract. The meat used in this medium is US sourced. Both toxins are detoxified with formaldehyde. The detoxified materials are then separately purified by serial ammonium sulfate fractionation and diafiltration.
The acellular pertussis vaccine components are isolated from culture fluids of Phase 1 Bordetella pertussis grown in a modified Stainer-Scholte medium.2 After purification by salt precipitation, ultracentrifugation, and ultrafiltration, preparations containing varying amounts of both pertussis toxin (PT) and filamentous hemagglutinin (FHA) are combined to obtain a 1:1 ratio and treated with formaldehyde to inactivate PT.
The diphtheria and tetanus toxoids are adsorbed using aluminum potassium sulfate (alum). The adsorbed toxoids are combined with acellular pertussis concentrate, and diluted to a final volume using sterile phosphate-buffered physiological saline.
Each 0.5 mL dose is formulated to contain 6.7 Lf of diphtheria toxoid and 5 Lf of tetanus toxoid (both toxoids induce at least 2 units of antitoxin per mL in the guinea pig potency test), and 46.8 mg of pertussis antigens. This is represented in the final vaccine as approximately 23.4 mg of inactivated PT and 23.4 mg of FHA. The inactivated acellular pertussis component contributes not more than 50 endotoxin units to the endotoxin content of 1 mL of DTaP. The potency of the pertussis components is evaluated by measuring the antibody response to PT and FHA in immunized mice using an ELISA system. The vaccine is formulated without preservatives, but contains a trace amount of thimerosal [(mercury derivative), (≤0.3 mg mercury/dose)] from the manufacturing process. Each 0.5 mL dose also contains, by assay, not more than 0.170 mg of aluminum and not more than 100 mg (0.02%) of residual formaldehyde. The vaccine contains gelatin and polysorbate 80 (Tween-80), which are used in the production of the pertussis concentrate.
Acellular Pertussis Vaccine Concentrates (For Further Manufacturing Use) are produced by The Research Foundation for Microbial Diseases of Osaka University (BIKEN), Osaka, Japan, under United States (US) license, and are combined with diphtheria and tetanus toxoids manufactured by AvP. Tripedia vaccine is filled, labeled, packaged, and released by AvP.
When Tripedia vaccine is used to reconstitute ActHIB[Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) manufactured by Aventis Pasteur SA] the combination vaccine is TriHIBit. Each single 0.5 mL dose of TriHIBit vaccine for the fourth dose only, is formulated to contain 6.7 Lf of diphtheria toxoid, 5 Lf of tetanus toxoid (both toxoids induce at least 2 units of antitoxin per mL in the guinea pig potency test), 46.8 mg of pertussis antigens (approximately 23.4 mg of inactivated PT and 23.4 mg of FHA), 10 mg of purified Haemophilus influenzae type b capsular polysaccharide conjugated to 24 mg of inactivated tetanus toxoid, and 8.5% sucrose. (Refer to ActHIB vaccine package insert.)
REFERENCES
1. Mueller JH, et al. Production of diphtheria toxin of high potency (100 Lf) on a reproducible medium. J Immunol 1941;40: 21-32.
2. Aventis Pasteur Inc. , Data on File 072503. Last reviewed on RxList: 6/8/2006




Tripedia Drug Description
Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Tripedia®
DRUG DESCRIPTION



What are the possible side effects of diphtheria, tetanus, and pertussis vaccines (Acel-Imune, Certiva, Daptacel, Infanrix, Tripedia)?

Keep track of any and all side effects your child has after receiving this vaccine. When the child receives the next booster dose, you will need to tell the doctor if the first shot caused any side effects. Getting diphtheria, tetanus, or pertussis disease is much riskier than getting DTaP vaccine. However, like any medicine, this vaccine, can cause side effects. The risk of DTaP vaccine causing a serious side effect is extremely...
Read All Potential Side Effects for Tripedia »




Tripedia®, Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP), for intramuscular use, is a sterile preparation of diphtheria and tetanus toxoids adsorbed, with acellular pertussis vaccine in an isotonic sodium chloride solution containing sodium phosphate to control pH. After shaking, the vaccine is a homogeneous white suspension. Tripedia vaccine is distributed by Aventis Pasteur Inc. (AvP).
Corynebacterium diphtheriae cultures are grown in a modified Mueller and Miller medium.1 Clostridium tetani cultures are grown in a peptone-based medium containing a bovine extract. The meat used in this medium is US sourced. Both toxins are detoxified with formaldehyde. The detoxified materials are then separately purified by serial ammonium sulfate fractionation and diafiltration.
The acellular pertussis vaccine components are isolated from culture fluids of Phase 1 Bordetella pertussis grown in a modified Stainer-Scholte medium.2 After purification by salt precipitation, ultracentrifugation, and ultrafiltration, preparations containing varying amounts of both pertussis toxin (PT) and filamentous hemagglutinin (FHA) are combined to obtain a 1:1 ratio and treated with formaldehyde to inactivate PT.
The diphtheria and tetanus toxoids are adsorbed using aluminum potassium sulfate (alum). The adsorbed toxoids are combined with acellular pertussis concentrate, and diluted to a final volume using sterile phosphate-buffered physiological saline.
Each 0.5 mL dose is formulated to contain 6.7 Lf of diphtheria toxoid and 5 Lf of tetanus toxoid (both toxoids induce at least 2 units of antitoxin per mL in the guinea pig potency test), and 46.8 mg of pertussis antigens. This is represented in the final vaccine as approximately 23.4 mg of inactivated PT and 23.4 mg of FHA. The inactivated acellular pertussis component contributes not more than 50 endotoxin units to the endotoxin content of 1 mL of DTaP. The potency of the pertussis components is evaluated by measuring the antibody response to PT and FHA in immunized mice using an ELISA system. The vaccine is formulated without preservatives, but contains a trace amount of thimerosal [(mercury derivative), (≤0.3 mg mercury/dose)] from the manufacturing process. Each 0.5 mL dose also contains, by assay, not more than 0.170 mg of aluminum and not more than 100 mg (0.02%) of residual formaldehyde. The vaccine contains gelatin and polysorbate 80 (Tween-80), which are used in the production of the pertussis concentrate.
Acellular Pertussis Vaccine Concentrates (For Further Manufacturing Use) are produced by The Research Foundation for Microbial Diseases of Osaka University (BIKEN), Osaka, Japan, under United States (US) license, and are combined with diphtheria and tetanus toxoids manufactured by AvP. Tripedia vaccine is filled, labeled, packaged, and released by AvP.
When Tripedia vaccine is used to reconstitute ActHIB[Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) manufactured by Aventis Pasteur SA] the combination vaccine is TriHIBit. Each single 0.5 mL dose of TriHIBit vaccine for the fourth dose only, is formulated to contain 6.7 Lf of diphtheria toxoid, 5 Lf of tetanus toxoid (both toxoids induce at least 2 units of antitoxin per mL in the guinea pig potency test), 46.8 mg of pertussis antigens (approximately 23.4 mg of inactivated PT and 23.4 mg of FHA), 10 mg of purified Haemophilus influenzae type b capsular polysaccharide conjugated to 24 mg of inactivated tetanus toxoid, and 8.5% sucrose. (Refer to ActHIB vaccine package insert.)
REFERENCES
1. Mueller JH, et al. Production of diphtheria toxin of high potency (100 Lf) on a reproducible medium. J Immunol 1941;40: 21-32.
2. Aventis Pasteur Inc. , Data on File 072503. Last reviewed on RxList: 6/8/2006




Tripedia Drug Description
Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Tripedia®
DRUG DESCRIPTION



What are the possible side effects of diphtheria, tetanus, and pertussis vaccines (Acel-Imune, Certiva, Daptacel, Infanrix, Tripedia)?

Keep track of any and all side effects your child has after receiving this vaccine. When the child receives the next booster dose, you will need to tell the doctor if the first shot caused any side effects. Getting diphtheria, tetanus, or pertussis disease is much riskier than getting DTaP vaccine. However, like any medicine, this vaccine, can cause side effects. The risk of DTaP vaccine causing a serious side effect is extremely...
Read All Potential Side Effects for Tripedia »




Tripedia®, Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP), for intramuscular use, is a sterile preparation of diphtheria and tetanus toxoids adsorbed, with acellular pertussis vaccine in an isotonic sodium chloride solution containing sodium phosphate to control pH. After shaking, the vaccine is a homogeneous white suspension. Tripedia vaccine is distributed by Aventis Pasteur Inc. (AvP).
Corynebacterium diphtheriae cultures are grown in a modified Mueller and Miller medium.1 Clostridium tetani cultures are grown in a peptone-based medium containing a bovine extract. The meat used in this medium is US sourced. Both toxins are detoxified with formaldehyde. The detoxified materials are then separately purified by serial ammonium sulfate fractionation and diafiltration.
The acellular pertussis vaccine components are isolated from culture fluids of Phase 1 Bordetella pertussis grown in a modified Stainer-Scholte medium.2 After purification by salt precipitation, ultracentrifugation, and ultrafiltration, preparations containing varying amounts of both pertussis toxin (PT) and filamentous hemagglutinin (FHA) are combined to obtain a 1:1 ratio and treated with formaldehyde to inactivate PT.
The diphtheria and tetanus toxoids are adsorbed using aluminum potassium sulfate (alum). The adsorbed toxoids are combined with acellular pertussis concentrate, and diluted to a final volume using sterile phosphate-buffered physiological saline.
Each 0.5 mL dose is formulated to contain 6.7 Lf of diphtheria toxoid and 5 Lf of tetanus toxoid (both toxoids induce at least 2 units of antitoxin per mL in the guinea pig potency test), and 46.8 mg of pertussis antigens. This is represented in the final vaccine as approximately 23.4 mg of inactivated PT and 23.4 mg of FHA. The inactivated acellular pertussis component contributes not more than 50 endotoxin units to the endotoxin content of 1 mL of DTaP. The potency of the pertussis components is evaluated by measuring the antibody response to PT and FHA in immunized mice using an ELISA system. The vaccine is formulated without preservatives, but contains a trace amount of thimerosal [(mercury derivative), (≤0.3 mg mercury/dose)] from the manufacturing process. Each 0.5 mL dose also contains, by assay, not more than 0.170 mg of aluminum and not more than 100 mg (0.02%) of residual formaldehyde. The vaccine contains gelatin and polysorbate 80 (Tween-80), which are used in the production of the pertussis concentrate.
Acellular Pertussis Vaccine Concentrates (For Further Manufacturing Use) are produced by The Research Foundation for Microbial Diseases of Osaka University (BIKEN), Osaka, Japan, under United States (US) license, and are combined with diphtheria and tetanus toxoids manufactured by AvP. Tripedia vaccine is filled, labeled, packaged, and released by AvP.
When Tripedia vaccine is used to reconstitute ActHIB[Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) manufactured by Aventis Pasteur SA] the combination vaccine is TriHIBit. Each single 0.5 mL dose of TriHIBit vaccine for the fourth dose only, is formulated to contain 6.7 Lf of diphtheria toxoid, 5 Lf of tetanus toxoid (both toxoids induce at least 2 units of antitoxin per mL in the guinea pig potency test), 46.8 mg of pertussis antigens (approximately 23.4 mg of inactivated PT and 23.4 mg of FHA), 10 mg of purified Haemophilus influenzae type b capsular polysaccharide conjugated to 24 mg of inactivated tetanus toxoid, and 8.5% sucrose. (Refer to ActHIB vaccine package insert.)
REFERENCES
1. Mueller JH, et al. Production of diphtheria toxin of high potency (100 Lf) on a reproducible medium. J Immunol 1941;40: 21-32.
2. Aventis Pasteur Inc. , Data on File 072503. Last reviewed on RxList: 6/8/2006




Tripedia Drug Description
Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Tripedia®
DRUG DESCRIPTION



What are the possible side effects of diphtheria, tetanus, and pertussis vaccines (Acel-Imune, Certiva, Daptacel, Infanrix, Tripedia)?

Keep track of any and all side effects your child has after receiving this vaccine. When the child receives the next booster dose, you will need to tell the doctor if the first shot caused any side effects. Getting diphtheria, tetanus, or pertussis disease is much riskier than getting DTaP vaccine. However, like any medicine, this vaccine, can cause side effects. The risk of DTaP vaccine causing a serious side effect is extremely...
Read All Potential Side Effects for Tripedia »




Tripedia®, Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP), for intramuscular use, is a sterile preparation of diphtheria and tetanus toxoids adsorbed, with acellular pertussis vaccine in an isotonic sodium chloride solution containing sodium phosphate to control pH. After shaking, the vaccine is a homogeneous white suspension. Tripedia vaccine is distributed by Aventis Pasteur Inc. (AvP).
Corynebacterium diphtheriae cultures are grown in a modified Mueller and Miller medium.1 Clostridium tetani cultures are grown in a peptone-based medium containing a bovine extract. The meat used in this medium is US sourced. Both toxins are detoxified with formaldehyde. The detoxified materials are then separately purified by serial ammonium sulfate fractionation and diafiltration.
The acellular pertussis vaccine components are isolated from culture fluids of Phase 1 Bordetella pertussis grown in a modified Stainer-Scholte medium.2 After purification by salt precipitation, ultracentrifugation, and ultrafiltration, preparations containing varying amounts of both pertussis toxin (PT) and filamentous hemagglutinin (FHA) are combined to obtain a 1:1 ratio and treated with formaldehyde to inactivate PT.
The diphtheria and tetanus toxoids are adsorbed using aluminum potassium sulfate (alum). The adsorbed toxoids are combined with acellular pertussis concentrate, and diluted to a final volume using sterile phosphate-buffered physiological saline.
Each 0.5 mL dose is formulated to contain 6.7 Lf of diphtheria toxoid and 5 Lf of tetanus toxoid (both toxoids induce at least 2 units of antitoxin per mL in the guinea pig potency test), and 46.8 mg of pertussis antigens. This is represented in the final vaccine as approximately 23.4 mg of inactivated PT and 23.4 mg of FHA. The inactivated acellular pertussis component contributes not more than 50 endotoxin units to the endotoxin content of 1 mL of DTaP. The potency of the pertussis components is evaluated by measuring the antibody response to PT and FHA in immunized mice using an ELISA system. The vaccine is formulated without preservatives, but contains a trace amount of thimerosal [(mercury derivative), (≤0.3 mg mercury/dose)] from the manufacturing process. Each 0.5 mL dose also contains, by assay, not more than 0.170 mg of aluminum and not more than 100 mg (0.02%) of residual formaldehyde. The vaccine contains gelatin and polysorbate 80 (Tween-80), which are used in the production of the pertussis concentrate.
Acellular Pertussis Vaccine Concentrates (For Further Manufacturing Use) are produced by The Research Foundation for Microbial Diseases of Osaka University (BIKEN), Osaka, Japan, under United States (US) license, and are combined with diphtheria and tetanus toxoids manufactured by AvP. Tripedia vaccine is filled, labeled, packaged, and released by AvP.
When Tripedia vaccine is used to reconstitute ActHIB[Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) manufactured by Aventis Pasteur SA] the combination vaccine is TriHIBit. Each single 0.5 mL dose of TriHIBit vaccine for the fourth dose only, is formulated to contain 6.7 Lf of diphtheria toxoid, 5 Lf of tetanus toxoid (both toxoids induce at least 2 units of antitoxin per mL in the guinea pig potency test), 46.8 mg of pertussis antigens (approximately 23.4 mg of inactivated PT and 23.4 mg of FHA), 10 mg of purified Haemophilus influenzae type b capsular polysaccharide conjugated to 24 mg of inactivated tetanus toxoid, and 8.5% sucrose. (Refer to ActHIB vaccine package insert.)
REFERENCES
1. Mueller JH, et al. Production of diphtheria toxin of high potency (100 Lf) on a reproducible medium. J Immunol 1941;40: 21-32.
2. Aventis Pasteur Inc. , Data on File 072503. Last reviewed on RxList: 6/8/2006





Other reviews about Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine on wordpress

Original Contribution - Combined Tetanus, Diphtheria, and 5-Component Pertussis Vaccine for Use in Adolescents and Adults
  by JOC
Source: JAMA Vol. 293 No. 24, June 22/29, 2005 p.3003-3011 Michael E. Pichichero, MD; Margaret B. Rennels, MD; Kathryn M. Edwards, MD; Mark M. Blatter, MD; Gary S. Marshall, […]


Original Contribution - Combined Tetanus, Diphtheria, and 5-Component Pertussis Vaccine for Use in Adolescents and Adults
  by JOC
Source: JAMA Vol. 293 No. 24, June 22/29, 2005 p.3003-3011. Michael E. Pichichero, MD; Margaret B. Rennels, MD; Kathryn M. Edwards, MD; Mark M. Blatter, MD; Gary S. Marshall, […]


Recommended Childhood and Adolescent Immunization Schedule --- United States, 2006: CDC
  by vorlon41
Recommended Childhood and Adolescent Immunization Schedule --- United States, 2006 Harmonized Childhood and Adolescent Immunization Schedule, 2006 The Advisory Committee on Immunization Practices (ACIP) periodically reviews the recommended childhood and […]


Whooping Cough Vaccine Boostrix
  by fischman
Vaccine candidate against pertussis (whooping cough) - A disease children are routinely vaccinated against but which is still on the rise in the United States. GlaxoSmithKline announced that its […]


INMUNIZATION - ESQUEMA DE VACUNACIÓN AAP
  by pediatraldia
 Immunization Schedule for Children and Teens Updated  January 8, 2008 — The American Academy of Pediatrics has issued an updated immunization schedule for children and adolescents aged 0 to […]


Drugs.com Lists "Autism" as Known Adverse Reaction to DTaP Vaccine Tripedia
  by kandylini
From Adventures in Autism: In Drugs.com's "A to Z Drug Facts" section the entry on Diphtheria / Tetanus Toxoids / Acellular Pertussis Vaccine contains the following Central Nervous System […]


Most Teens Ages 13 to 17 Are Vaccinated
  by heremias
The Centers for Disease Control and Prevention (CDC) recently estimated that as of 2007, 89.5% of teens between the ages of 13 and 17 have received […]


This is EVIL! I think I am gonna be SICK!
  by forcedanarchy
PAY CLOSE ATTENTION! They are now openly advocating the promotion of vaccines through fear!"One promising tactic is "social marketing" that promotes immunization based on emotion, rather than medicine's […]


Vaccines | Aborted Fetal Tissue, Pig Ingredients
  by Joey
Unclean indeed. Vaccines aren't just dangerous, they're unclean: Vaccines Unclean? Rubella and Rabies Grown in Aborted Human Fetal Cells, others grown in Mice, Pig Gelatin, other sources The following is […]


Who's in for Cocktails?
  by hasselfamilychiropractic
Vaccines are Toxic Cocktails for Children  By Patty Donovan Right now there is a campaign to get everyone vaccinated against H1N1 flu, a disease that to a large degree […]



Other reviews about Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine on web:

Diphtheria/Tetanus Toxoids/Acellular Pertussis Vaccine (DTaP/Tdap) professional patient advice. Specific and up to date information about Diphtheria/Tetanus Toxoids/Acellular ... Complete Diphtheria/Tetanus Toxoids/Acellular Pertussis Vaccine ...


Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use ...


Acel-Immune Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed: Manufacturer: Lederle Laboratories: Microorganism: The bacterial toxins C. diphtheriae and ... WAVE - Specific Vaccines Tetanus


Use of Diphtheria Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose Series Supplemental Recommendations of the Advisory Committee on Immunization Practices (ACIP) Use of Diphtheria Toxoid-Tetanus Toxoid-Acellular Pertussis ...


The vaccine components include diphtheria and tetanus toxoids, and killed whole cells of the ... the "a" in "ap" indicates that the pertussis toxoids are acellular. Two Tdap vaccines ... DPT vaccine - Wikipedia, the free encyclopedia


Acel-Immune Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed: Manufacturer: Lederle Laboratories: Microorganism: The bacterial toxins C. diphtheriae and ... WAVE - Specific Vaccines Pertussis (whooping cough)


sanofi pasteur DAPTACEL ® 07 March 2008 253 - DAPTACEL ® R5-0308 DAPTACEL-USPI Page 1 of 24 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the ... Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine ...


Page 1of 12 AHFS Category 80:08 Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed DAPTA CEL ® DESCRIPTION DAPTA CEL ®, Diphtheria and Tetanus Toxoids ... Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine ...


Sanofi Pasteur Package Insert 306 œ Adacel ® 1 Tetanus Toxoid, Reduced Tdap Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Adacel ® 1 DESCRIPTION 2 Adacel ... Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis ...


DIPHTHERIA TETANUS & PERTUSSIS VACCINES Diphtheria, tetanus, and pertussis are serious diseases caused by bacteria . Diphtheria and pertussis are spread from person to person. DIPHTHERIA TETANUS & PERTUSSIS





Featured Reviews

Reviews Gatifloxacin Ophthalmic Solution

Zymaxid Drug Description ZYMAXID™ (gatifloxacin) Ophthalmic Solution 0.5% DRUG DESCRIPTION ZYMAXID™ sterile ophthalmic solution is an 8-methoxyfluoroquinolone anti-infective for the treatment of bacterial conjunctivitis. Its...
Read More  |  Review This
Reviews Antara

Antara Drug Description Antara® (fenofibrate) Capsules DRUG DESCRIPTION What are the possible side effects of fenofibrate? Fenofibrate has been associated with a rare but serious side effect of the muscles. Contact your doctor...
Read More  |  Review This
Reviews Rosiglitazone Maleate

Avandia Drug Description AVANDIA® (rosiglitazone maleate) Tablets WARNING CONGESTIVE HEART FAILURE AND MYOCARDIAL ISCHEMIA Thiazolidinediones, including rosiglitazone, cause or exacerbate congestive heart failure in some...
Read More  |  Review This
Reviews Ziconotide

Prialt Drug Description PRIALT® (ziconotide) Intrathecal Infusion For use only in the Medtronic SynchroMed® EL, SynchroMed® II Infusion System and CADD-Micro® ambulatory infusion pump WARNING: Severe psychiatric symptoms...
Read More  |  Review This
Reviews Tolterodine Tartrate

Detrol Drug Description Detrol® (tolterodine tartrate) Tablets DRUG DESCRIPTION What are the possible side effects of tolterodine (Detrol, Detrol LA)? Get emergency medical help if you have any of these signs of an allergic...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....